These meta-analyses found no statistically significant differences between the efficacy of propranolol and benzodiazepines regarding the short-term treatment of panic disorder with or without agoraphobia .
Also , no evidence was found for effects of propranolol on PTSD symptom severity through inhibition of memory reconsolidation .
In conclusion , the quality of evidence for the efficacy of propranolol at present is insufficient to support the routine use of propranolol in the treatment of any of the anxiety disorders
The effects of propranolol in the treatment of anxiety disorders have not been systematic ally evaluated previously .
The aim was to conduct a systematic review and meta- analysis of r and omised controlled trials , addressing the efficacy of oral propranolol versus placebo or other medication as a treatment for alleviating either state or trait anxiety in patients suffering from anxiety disorders .
The assessment and treatment of performance anxiety in musicians.
OBJECTIVE Performance anxiety in musicians may be severe enough to require intervention but has been the subject of relatively little clinical research . The authors ' objectives were to describe the results of a comprehensive clinical and laboratory assessment and to perform a double-blind , placebo-controlled study comparing buspirone , cognitive-behavior therapy , and the combination of these treatments for performance anxiety . METHOD Ninety-four subjects were recruited by mass media announcements and were seen in a university-based outpatient psychiatric clinic . Assessment s were 1 ) question naires for all 94 subjects , 2 ) diagnostic interview of 50 subjects , and 3 ) laboratory performance of 34 subjects . Treatment conditions were 1 ) 6 weeks of buspirone , 2 ) 6 weeks of placebo , 3 ) a five-session , group cognitive-behavior therapy program with buspirone , or 4 ) the cognitive-behavior therapy program with placebo . Treatment outcome measures included subjective anxiety ratings and heart rate measures during a laboratory performance , a question naire measure of performance confidence , and a blind rating of musical performance quality . RESULTS All subjects fulfilled criteria for DSM-III-R social phobia . Of the 15 full-time professional musicians , ten had tried propranolol and three had stopped performing . Most of the subjects had substantial anxiety and heart rate increases during laboratory speech and musical performances . Cognitive-behavior therapy result ed in statistically significant reductions in subjective anxiety , improved quality of musical performance , and improved performance confidence .  Buspirone was not an effective treatment . CONCLUSIONS Cognitive-behavior therapy is a viable treatment approach for performance anxiety in musicians
These meta-analyses found no statistically significant differences between the efficacy of propranolol and benzodiazepines regarding the short-term treatment of panic disorder with or without agoraphobia .
Also , no evidence was found for effects of propranolol on PTSD symptom severity through inhibition of memory reconsolidation .
In conclusion , the quality of evidence for the efficacy of propranolol at present is insufficient to support the routine use of propranolol in the treatment of any of the anxiety disorders
The effects of propranolol in the treatment of anxiety disorders have not been systematic ally evaluated previously .
The aim was to conduct a systematic review and meta- analysis of r and omised controlled trials , addressing the efficacy of oral propranolol versus placebo or other medication as a treatment for alleviating either state or trait anxiety in patients suffering from anxiety disorders .